Preparing for the Next Influenza Pandemic: The Development of a Universal Influenza Vaccine

por Crank, Michelle C, Mascola, John R, Graham, Barney S
Publicado 2019

Next-generation influenza vaccines: opportunities and challenges

por Wei, Chih-Jen, Crank, Michelle C., Shiver, John, Graham, Barney S., Mascola, John R., Nabel, Gary J.
Publicado 2020

Author Correction: Next-generation influenza vaccines: opportunities and challenges

por Wei, Chih-Jen, Crank, Michelle C., Shiver, John, Graham, Barney S., Mascola, John R., Nabel, Gary J.
Publicado 2020

CD4 T cell epitope abundance in ferritin core potentiates responses to hemagglutinin nanoparticle vaccines

por Nelson, Sean A., Richards, Katherine A., Glover, Maryah A., Chaves, Francisco A., Crank, Michelle C., Graham, Barney S., Kanekiyo, Masaru, Sant, Andrea J.
Publicado 2022

Use of Hemagglutinin Stem Probes Demonstrate Prevalence of Broadly Reactive Group 1 Influenza Antibodies in Human Sera

por Yassine, Hadi M., McTamney, Patrick M., Boyington, Jeffery C., Ruckwardt, Tracy J., Crank, Michelle C., Smatti, Maria K., Ledgerwood, Julie E., Graham, Barney S.
Publicado 2018

A comprehensive influenza reporter virus panel for high-throughput deep profiling of neutralizing antibodies

por Creanga, Adrian, Gillespie, Rebecca A., Fisher, Brian E., Andrews, Sarah F., Lederhofer, Julia, Yap, Christina, Hatch, Liam, Stephens, Tyler, Tsybovsky, Yaroslav, Crank, Michelle C., Ledgerwood, Julie E., McDermott, Adrian B., Mascola, John R., Graham, Barney S., Kanekiyo, Masaru
Publicado 2021

Safety and Immunogenicity of a rAd35-EnvA Prototype HIV-1 Vaccine in Combination with rAd5-EnvA in Healthy Adults (VRC 012)

por Crank, Michelle C., Wilson, Eleanor M. P., Novik, Laura, Enama, Mary E., Hendel, Cynthia S., Gu, Wenjuan, Nason, Martha C., Bailer, Robert T., Nabel, Gary J., McDermott, Adrian B., Mascola, John R., Koup, Richard A., Ledgerwood, Julie E., Graham, Barney S.
Publicado 2016

Phase 1 Study of Pandemic H1 DNA Vaccine in Healthy Adults

por Crank, Michelle C., Gordon, Ingelise J., Yamshchikov, Galina V., Sitar, Sandra, Hu, Zonghui, Enama, Mary E., Holman, LaSonji A., Bailer, Robert T., Pearce, Melissa B., Koup, Richard A., Mascola, John R., Nabel, Gary J., Tumpey, Terrence M., Schwartz, Richard M., Graham, Barney S., Ledgerwood, Julie E.
Publicado 2015

Glycan repositioning of influenza hemagglutinin stem facilitates the elicitation of protective cross-group antibody responses

por Boyoglu-Barnum, Seyhan, Hutchinson, Geoffrey B., Boyington, Jeffrey C., Moin, Syed M., Gillespie, Rebecca A., Tsybovsky, Yaroslav, Stephens, Tyler, Vaile, John R., Lederhofer, Julia, Corbett, Kizzmekia S., Fisher, Brian E., Yassine, Hadi M., Andrews, Sarah F., Crank, Michelle C., McDermott, Adrian B., Mascola, John R., Graham, Barney S., Kanekiyo, Masaru
Publicado 2020

An avian influenza H7 DNA priming vaccine is safe and immunogenic in a randomized phase I clinical trial

por DeZure, Adam D., Coates, Emily E., Hu, Zonghui, Yamshchikov, Galina V., Zephir, Kathryn L., Enama, Mary E., Plummer, Sarah H., Gordon, Ingelise J., Kaltovich, Florence, Andrews, Sarah, McDermott, Adrian, Crank, Michelle C., Koup, Richard A, Schwartz, Richard M., Bailer, Robert T., Sun, Xiangjie, Mascola, John R., Tumpey, Terrence M., Graham, Barney S., Ledgerwood, Julie E.
Publicado 2017

Design of Nanoparticulate Group 2 Influenza Virus Hemagglutinin Stem Antigens That Activate Unmutated Ancestor B Cell Receptors of Broadly Neutralizing Antibody Lineages

por Corbett, Kizzmekia S., Moin, Syed M., Yassine, Hadi M., Cagigi, Alberto, Kanekiyo, Masaru, Boyoglu-Barnum, Seyhan, Myers, Sky I., Tsybovsky, Yaroslav, Wheatley, Adam K., Schramm, Chaim A., Gillespie, Rebecca A., Shi, Wei, Wang, Lingshu, Zhang, Yi, Andrews, Sarah F., Joyce, M. Gordon, Crank, Michelle C., Douek, Daniel C., McDermott, Adrian B., Mascola, John R., Graham, Barney S., Boyington, Jeffrey C.
Publicado 2019

Quadrivalent influenza nanoparticle vaccines induce broad protection

por Boyoglu-Barnum, Seyhan, Ellis, Daniel, Gillespie, Rebecca A., Hutchinson, Geoffrey B., Park, Young-Jun, Moin, Syed M., Acton, Oliver J., Ravichandran, Rashmi, Murphy, Mike, Pettie, Deleah, Matheson, Nick, Carter, Lauren, Creanga, Adrian, Watson, Michael J., Kephart, Sally, Ataca, Sila, Vaile, John R., Ueda, George, Crank, Michelle C., Stewart, Lance, Lee, Kelly K., Guttman, Miklos, Baker, David, Mascola, John R., Veesler, David, Graham, Barney S., King, Neil P., Kanekiyo, Masaru
Publicado 2021

Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial

por Houser, Katherine V., Chen, Grace L., Carter, Cristina, Crank, Michelle C., Nguyen, Thuy A., Burgos Florez, Maria Claudia, Berkowitz, Nina M., Mendoza, Floreliz, Hendel, Cynthia Starr, Gordon, Ingelise J., Coates, Emily E., Vazquez, Sandra, Stein, Judy, Case, Christopher L., Lawlor, Heather, Carlton, Kevin, Gaudinski, Martin R., Strom, Larisa, Hofstetter, Amelia R., Liang, C. Jason, Narpala, Sandeep, Hatcher, Christian, Gillespie, Rebecca A., Creanga, Adrian, Kanekiyo, Masaru, Raab, Julie E., Andrews, Sarah F., Zhang, Yi, Yang, Eun Sung, Wang, Lingshu, Leung, Kwanyee, Kong, Wing-Pui, Freyn, Alec W., Nachbagauer, Raffael, Palese, Peter, Bailer, Robert T., McDermott, Adrian B., Koup, Richard A., Gall, Jason G., Arnold, Frank, Mascola, John R., Graham, Barney S., Ledgerwood, Julie E.
Publicado 2022